PRICE T ROWE ASSOCIATES INC /MD/

Holdings History for UroGen Pharma Ltd. - Ordinary Shares, par value NIS 0.01 per share (URGN)

Symbol: URGN on Nasdaq
Investment type: Equity / Ordinary Shares, par value NIS 0.01 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$14,441,000	616,606	+259,991	+73%	$23.42	Q4 2025
30 Sep 2025	0%	-0%	$7,116,000	356,615	-4,826	-1.3%	$19.95	Q3 2025
30 Jun 2025	0%	-0%	$4,953,000	361,441	-7,213	-2%	$13.70	Q2 2025
31 Mar 2025	0%	-0%	$4,079,000	368,654	-25,330		$11.06	Q1 2025
31 Dec 2024	0%	+0%	$4,197,000	393,984	+381,145	+2969%	$10.65	Q4 2024
30 Sep 2024	0%	+0%	$164,000	12,839	+1,891	+17%	$12.77	Q3 2024
30 Jun 2024	0%	-0%	$184,000	10,948	-256,195	-96%	$16.81	Q2 2024
31 Mar 2024	0%	+0%	$4,008,000	267,143	+267,143	NEW	$15.00	Q1 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.